International Journal of Cardiology
Volume 135, Issue 3 , Pages 331-337, 10 July 2009

Influence of pre-hypertension on all-cause and cardiovascular mortality: The Singapore Cardiovascular Cohort Study☆☆☆

  • Jeannette Lee

      Affiliations

    • Community, Occupational and Family Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
    • Corresponding Author InformationCorresponding author. Community, Occupational and Family Medicine, Yong Loo Lin School of Medicine, MD3, National University of Singapore, 16 Medical Drive, Singapore 117597, Singapore. Tel.: +65 65164964; fax: +65 67791489.
    • ,
  • Derrick Heng

      Affiliations

    • Ministry of Health, Singapore
    • ,
  • Stefan Ma

      Affiliations

    • Ministry of Health, Singapore
    • ,
  • Suok-Kai Chew

      Affiliations

    • Ministry of Health, Singapore
    • ,
  • Kenneth Hughes

      Affiliations

    • Community, Occupational and Family Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
    • ,
  • E-Shyong Tai

      Affiliations

    • Department of Endocrinology, Singapore General Hospital, Singapore

Received 15 October 2007; received in revised form 16 January 2008; accepted 29 March 2008. published online 27 June 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Source of funding: This study was supported by an unrestricted educational grant from Pfizer Pte Ltd (Singapore).

☆☆ Conflict(s) of interest/disclosure(s): None. Pfizer had no involvement in the data collection, analysis, interpretation of the data, writing of the manuscript, or decision to submit the paper for publication.

PII: S0167-5273(08)00541-X

doi:10.1016/j.ijcard.2008.03.067

International Journal of Cardiology
Volume 135, Issue 3 , Pages 331-337, 10 July 2009

Article Tools